文献速递细胞病理与分子病理神经与头颈病理

米兰系统报告唾液腺细胞病理学的5年机构经验

The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
PubMed 文献 · Cancer Cytopathol · 2018-05-24

该研究回顾性分析了627例唾液腺细针穿刺标本,按米兰系统(MSRSGC)重新分类,评估各分类的风险恶性肿瘤(ROM)。两位细胞病理学家分类几乎完全一致(99.8%),非诊断性、非肿瘤性、良性肿瘤、AUS、SUMP、SFM和恶性的ROM分别为6.7%、7.1%、38.9%、5.0%、34.2%、92.9%和92.3%,不确定类别总体ROM为47.1%。MSRSGC有助于标准化报告和术前分层。

要点

  • MSRSGC分类一致性高,两位病理学家一致率99.8%。
  • 不确定类别(AUS、SUMP、SFM)总体ROM为47.1%。
  • SFM和恶性类别的ROM分别为92.9%和92.3%。

核心结论

  • MSRSGC是有价值的工具,可标准化报告并术前分层。
  • 更好地理解不确定诊断有助于细化风险分类标准。

研究设计与样本

  • 回顾性研究,纳入2011至2016年627例唾液腺FNA标本,373例有随访。
  • 由2名独立细胞病理学家按MSRSGC重新分类。

主要发现

  • 非诊断性、非肿瘤性、良性肿瘤、AUS、SUMP、SFM和恶性的ROM分别为6.7%、7.1%、38.9%、5.0%、34.2%、92.9%和92.3%。
  • 不确定类别(AUS、SUMP、SFM)总体ROM为47.1%。
  • 唾液腺FNA的敏感性、特异性、阴性预测值和阳性预测值分别为79%、98%、94%和92%。
  • 两位细胞病理学家分类一致率99.8%(626/627),1例不一致。

临床怎么用

  • 采用MSRSGC标准化唾液腺FNA报告,便于术前风险分层。
  • 关注不确定类别(AUS、SUMP、SFM),其总体ROM较高。

局限性

  • 回顾性研究,仅373例有随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration (FNA) is widely accepted in the preoperative management of salivary gland lesions. The proposed Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) aims to standardize reporting terminology. Studies regarding the risk of malignancy (ROM) for the proposed categories continue to evolve. The current retrospective study applied the MSRSGC to assess ROM for salivary gland lesions and focused on the "indeterminate" categories. METHODS: A total of 627 salivary gland FNA specimens obtained from 2011 through 2016 were retrieved, with follow-up available for 373 cases. The original diagnoses were recategorized using MSRSGC by 2 independent cytopathologists as: 1) non-diagnostic; 2) non-neoplastic; 3) atypia of undetermined significance (AUS); 4a) benign neoplasms; 4b) salivary gland neoplasm of uncertain malignant potential (SUMP); 5) suspicious for malignancy (SFM); and 6) malignant. The ROM and overall ROM for each diagnostic category were determined, with characterization of "indeterminate" (AUS, SUMP, and SFM) lesions. RESULTS: There was near-perfect agreement regarding categorization (626 of 627 cases; 99.8%) between the 2 cytopathologists, with discordance observed for 1 case. The sensitivity, specificity, negative predictive value, and positive predictive value of salivary gland FNA specimens at the study institution were 79%, 98%, 94%, and 92%, respectively. The ROM for non-diagnostic, non-neoplastic, benign neoplasms, AUS, SUMP, SFM, and malignant were 6.7%, 7.1%, 38.9%, 5.0%, 34.2%, 92.9%, and 92.3%, respectively. The indeterminate category had an overall ROM of 47.1%. CONCLUSIONS: The MSRSGC is a valuable tool that can help to standardize reporting and stratify cases preoperatively. Having a better understanding of the indeterminate diagnoses will help further refine risk classification criteria. Cancer Cytopathol 2018. © 2018 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Viswanathan K, Sung S, Scognamiglio T, et al. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience. Cancer Cytopathol. 2018. PMID: 29797690. doi:10.1002/cncy.22016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。